Indication
Dravet syndrome
Dravet syndrome is a rare, severe developmental and epileptic encephalopathy that typically presents during the first year of life in otherwise developmentally normal infants. Read more about Dravet syndrome
9 drugs 7 manufacturers
Drugs that treat it
Common Dravet syndrome therapies.
DIACOMIT (stiripentol)
DIACOMIT (stiripentol)
FINTEPLA (fenfluramine HCl)
EPIDIOLEX (cannabidiol (CBD))
EPIDIOLEX (cannabidiol (CBD))
FINTEPLA (fenfluramine HCl)
DIACOMIT (stiripentol)
DIACOMIT (stiripentol)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDravet syndrome is a rare, severe developmental and epileptic encephalopathy that typically presents during the first year of life in otherwise developmentally normal infants.
Affecting the central nervous system, it is predominantly driven by loss-of-function variants in the SCN1A gene, which encodes the alpha-1 subunit of voltage-gated sodium channels critical for inhibitory neuronal function.
The condition is clinically characterized by prolonged, drug-resistant convulsive seizures—often febrile, hemiclonic, or generalized tonic-clonic—with a marked susceptibility to status epilepticus.
As the disease progresses, children often develop diverse seizure types, motor and gait abnormalities, sleep disturbances, and progressive neurodevelopmental delays leading to intellectual disability.
- nih.gov
Dravet syndrome is a rare, severe developmental and epileptic encephalopathy that typically presents during the first year of life in otherwise developmentally normal infants Affecting the central nervous system, it is predominantly driven by loss-of-function variants in the SCN1A gene, which encodes the alpha-1 subunit of voltage-gated sodium channels critical for inhibitory neuronal function The condition is clinically characterized by prolonged, drug-resistant convulsive seizures—often febril...
- medlink.com
Dravet syndrome is a rare, severe developmental and epileptic encephalopathy that typically presents during the first year of life in otherwise developmentally normal infants Affecting the central nervous system, it is predominantly driven by loss-of-function variants in the SCN1A gene, which encodes the alpha-1 subunit of voltage-gated sodium channels critical for inhibitory neuronal function The condition is clinically characterized by prolonged, drug-resistant convulsive seizures—often febril...
- chop.edu
The condition is clinically characterized by prolonged, drug-resistant convulsive seizures—often febrile, hemiclonic, or generalized tonic-clonic—with a marked susceptibility to status epilepticus
- epilepsydiagnosis.org
As the disease progresses, children often develop diverse seizure types, motor and gait abnormalities, sleep disturbances, and progressive neurodevelopmental delays leading to intellectual disability
Personalize your experience
Follow Dravet syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.